Global Neurological Biomarkers Market Overview And Scope:
Global Neurological Biomarkers Market Size was estimated at USD 6925.42 million in 2022 and is projected to reach USD 13757.66 million by 2028, exhibiting a CAGR of 12.12% during the forecast period.
The Global Neurological Biomarkers Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Neurological Biomarkers utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, Roche, Illumina, Bio-Rad Laboratories, QIAGEN, Myriad RBM, Cisbio Bioassays, Athena Diagnostics, BGI, Wuxi APP, Aepodia, Proteome Sciences, Genewiz
Global Neurological Biomarkers Market Segmentation
By Type, Neurological Biomarkers market has been segmented into:Proteomics
Genomics
Imaging
Bioinformatics
Others
By Application, Neurological Biomarkers market has been segmented into:
Diagnostics
Drug Discovery
Personalized Medicine
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Neurological Biomarkers market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Neurological Biomarkers market.
Top Key Players Covered in Neurological Biomarkers market are:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Objective to buy this Report:
1. Neurological Biomarkers analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Neurological Biomarkers market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Neurological Biomarkers Market by Type
5.1 Neurological Biomarkers Market Overview Snapshot and Growth Engine
5.2 Neurological Biomarkers Market Overview
5.3 Proteomics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Proteomics: Geographic Segmentation
5.4 Genomics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Genomics: Geographic Segmentation
5.5 Imaging
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Imaging: Geographic Segmentation
5.6 Bioinformatics
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Bioinformatics: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
Chapter 6: Neurological Biomarkers Market by Application
6.1 Neurological Biomarkers Market Overview Snapshot and Growth Engine
6.2 Neurological Biomarkers Market Overview
6.3 Diagnostics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Diagnostics: Geographic Segmentation
6.4 Drug Discovery
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Drug Discovery: Geographic Segmentation
6.5 Personalized Medicine
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Personalized Medicine: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Neurological Biomarkers Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Neurological Biomarkers Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Neurological Biomarkers Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 THERMO FISHER SCIENTIFIC
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MERCK
7.4 QUEST DIAGNOSTICS
7.5 ABBOTT
7.6 ROCHE
7.7 ILLUMINA
7.8 BIO-RAD LABORATORIES
7.9 QIAGEN
7.10 MYRIAD RBM
7.11 CISBIO BIOASSAYS
7.12 ATHENA DIAGNOSTICS
7.13 BGI
7.14 WUXI APP
7.15 AEPODIA
7.16 PROTEOME SCIENCES
7.17 GENEWIZ
Chapter 8: Global Neurological Biomarkers Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Proteomics
8.2.2 Genomics
8.2.3 Imaging
8.2.4 Bioinformatics
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Diagnostics
8.3.2 Drug Discovery
8.3.3 Personalized Medicine
8.3.4 Others
Chapter 9: North America Neurological Biomarkers Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Proteomics
9.4.2 Genomics
9.4.3 Imaging
9.4.4 Bioinformatics
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Diagnostics
9.5.2 Drug Discovery
9.5.3 Personalized Medicine
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Neurological Biomarkers Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Proteomics
10.4.2 Genomics
10.4.3 Imaging
10.4.4 Bioinformatics
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Diagnostics
10.5.2 Drug Discovery
10.5.3 Personalized Medicine
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Neurological Biomarkers Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Proteomics
11.4.2 Genomics
11.4.3 Imaging
11.4.4 Bioinformatics
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Diagnostics
11.5.2 Drug Discovery
11.5.3 Personalized Medicine
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Neurological Biomarkers Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Proteomics
12.4.2 Genomics
12.4.3 Imaging
12.4.4 Bioinformatics
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Diagnostics
12.5.2 Drug Discovery
12.5.3 Personalized Medicine
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Neurological Biomarkers Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Proteomics
13.4.2 Genomics
13.4.3 Imaging
13.4.4 Bioinformatics
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Diagnostics
13.5.2 Drug Discovery
13.5.3 Personalized Medicine
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Neurological Biomarkers Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Proteomics
14.4.2 Genomics
14.4.3 Imaging
14.4.4 Bioinformatics
14.4.5 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Diagnostics
14.5.2 Drug Discovery
14.5.3 Personalized Medicine
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Neurological Biomarkers Scope:
|
Report Data
|
Neurological Biomarkers Market
|
|
Neurological Biomarkers Market Size in 2025
|
USD XX million
|
|
Neurological Biomarkers CAGR 2025 - 2032
|
XX%
|
|
Neurological Biomarkers Base Year
|
2024
|
|
Neurological Biomarkers Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, Roche, Illumina, Bio-Rad Laboratories, QIAGEN, Myriad RBM, Cisbio Bioassays, Athena Diagnostics, BGI, Wuxi APP, Aepodia, Proteome Sciences, Genewiz.
|
|
Key Segments
|
By Type
Proteomics
Genomics
Imaging
Bioinformatics
Others
By Applications
Diagnostics
Drug Discovery
Personalized Medicine
Others
|
